Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-23.58 Million ≈ $-3.45 Million USD) by net assets (CN¥3.18 Billion ≈ $465.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Jolly Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Jolly Pharmaceutical Co Ltd (300181) financial obligations for a breakdown of total debt and financial obligations.

Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Jolly Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Urban Construction Investment & Development Co Ltd SHG:600266	0.036x
Jaya Sukses Makmur Sentosa Tbk PT JK:RISE	-0.018x
Lihuayi Weiyuan Chemical Co Ltd SHG:600955	0.006x
Timah Persero Tbk JK:TINS	-0.113x
Sunward Intelligent Equipment Co Ltd SHE:002097	0.016x
Oruka Therapeutics, Inc. NASDAQ:ORKA	-0.044x
Pharma Mar S.A. MC:PHM	0.133x
Yunnan Salt & Salt Chemical Industry Co Ltd SHE:002053	0.032x

Annual Cash Flow Conversion Efficiency for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 300181 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.82 Billion ≈ $412.57 Million	CN¥297.05 Million ≈ $43.47 Million	0.105x	+1.31%
2023-12-31	CN¥2.77 Billion ≈ $405.92 Million	CN¥288.46 Million ≈ $42.21 Million	0.104x	-9.91%
2022-12-31	CN¥2.76 Billion ≈ $403.86 Million	CN¥318.59 Million ≈ $46.62 Million	0.115x	-9.08%
2021-12-31	CN¥1.98 Billion ≈ $290.21 Million	CN¥251.80 Million ≈ $36.85 Million	0.127x	-21.95%
2020-12-31	CN¥1.72 Billion ≈ $251.61 Million	CN¥279.69 Million ≈ $40.93 Million	0.163x	+77.59%
2019-12-31	CN¥1.41 Billion ≈ $206.00 Million	CN¥128.94 Million ≈ $18.87 Million	0.092x	+62.31%
2018-12-31	CN¥1.39 Billion ≈ $203.01 Million	CN¥78.28 Million ≈ $11.46 Million	0.056x	+1192.59%
2017-12-31	CN¥1.49 Billion ≈ $218.09 Million	CN¥6.51 Million ≈ $952.09K	0.004x	-88.98%
2016-12-31	CN¥1.47 Billion ≈ $215.38 Million	CN¥58.30 Million ≈ $8.53 Million	0.040x	-41.45%
2015-12-31	CN¥1.44 Billion ≈ $210.07 Million	CN¥97.13 Million ≈ $14.21 Million	0.068x	+330.67%
2014-12-31	CN¥871.76 Million ≈ $127.57 Million	CN¥13.70 Million ≈ $2.00 Million	0.016x	-58.87%
2013-12-31	CN¥772.52 Million ≈ $113.04 Million	CN¥29.50 Million ≈ $4.32 Million	0.038x	-11.63%
2012-12-31	CN¥705.92 Million ≈ $103.30 Million	CN¥30.51 Million ≈ $4.46 Million	0.043x	+116.47%
2011-12-31	CN¥683.92 Million ≈ $100.08 Million	CN¥13.65 Million ≈ $2.00 Million	0.020x	-93.61%
2010-12-31	CN¥207.17 Million ≈ $30.32 Million	CN¥64.78 Million ≈ $9.48 Million	0.313x	+18.04%
2009-12-31	CN¥165.70 Million ≈ $24.25 Million	CN¥43.89 Million ≈ $6.42 Million	0.265x	+26.77%
2008-12-31	CN¥149.11 Million ≈ $21.82 Million	CN¥31.16 Million ≈ $4.56 Million	0.209x	+88.11%
2007-12-31	CN¥144.47 Million ≈ $21.14 Million	CN¥16.05 Million ≈ $2.35 Million	0.111x	--

About Zhejiang Jolly Pharmaceutical Co Ltd

SHE:300181 China Drug Manufacturers - General

Market Cap

$1.56 Billion

CN¥10.67 Billion CNY

Market Cap Rank

#7226 Global

#1710 in China

Share Price

CN¥15.21

Change (1 day)

-1.36%

52-Week Range

CN¥14.94 - CN¥20.53

All Time High

CN¥20.53